Xeraya Cove Ltd - Jul 24, 2023 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Group Member
Signature
Xeraya Cove Ltd By: /s/ Fares Zahir, Director
Stock symbol
GRNA
Transactions as of
Jul 24, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 05:01 PM
Previous filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRNA Common Stock Other -1.73M -100% 0 Jul 24, 2023 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Xeraya Cove Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On July 24, 2023, pursuant to the Contribution and Exchange Agreement dated as of May 29, 2023, Xeraya Cove Ltd ("Xeraya") contributed all of its shares of Common Stock to SW ParentCo, Inc. ("Parent") in exchange for shares of Series A-2 Preferred Stock of Parent.
F2 These securities are held of record by Xeraya. Fares Zahir, a natural person, is a director of Xeraya and has sole voting and dispositive power with respect to the securities held by Xeraya. By virtue of such relationship Mr. Zahir may be deemed to have beneficial ownership over such securities, but disclaims beneficial ownership except to the extent of his pecuniary interest therein.